At the 3rd Annual Sonoma Eye, meeting, Dr. Novack chaired a symposium on two areas of interest – basic research in ocular inflammation and retinal disease and clinical outcomes.  Dr. Novack presented current thinking on endpoints in approvals of novel therapeutics in ophthalmology.  He also moderated the discussion on how to best use pre-clinical models to aid in drug development.  Including Dr. Novack, there were 3 speakers from the University of California, Davis.